Omnicell Statistics
Total Valuation
Omnicell has a market cap or net worth of $1.45 billion. The enterprise value is $1.43 billion.
| Market Cap | 1.45B |
| Enterprise Value | 1.43B |
Important Dates
The last earnings date was Thursday, July 31, 2025, before market open.
| Earnings Date | Jul 31, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Omnicell has 45.93 million shares outstanding. The number of shares has increased by 2.30% in one year.
| Current Share Class | 45.93M |
| Shares Outstanding | 45.93M |
| Shares Change (YoY) | +2.30% |
| Shares Change (QoQ) | +0.84% |
| Owned by Insiders (%) | 2.38% |
| Owned by Institutions (%) | 101.02% |
| Float | 44.82M |
Valuation Ratios
The trailing PE ratio is 63.87 and the forward PE ratio is 20.36. Omnicell's PEG ratio is 3.44.
| PE Ratio | 63.87 |
| Forward PE | 20.36 |
| PS Ratio | 1.27 |
| Forward PS | 1.22 |
| PB Ratio | 1.15 |
| P/TBV Ratio | 4.97 |
| P/FCF Ratio | 13.55 |
| P/OCF Ratio | 9.80 |
| PEG Ratio | 3.44 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 19.35, with an EV/FCF ratio of 13.41.
| EV / Earnings | 62.08 |
| EV / Sales | 1.25 |
| EV / EBITDA | 19.35 |
| EV / EBIT | 82.13 |
| EV / FCF | 13.41 |
Financial Position
The company has a current ratio of 1.42, with a Debt / Equity ratio of 0.30.
| Current Ratio | 1.42 |
| Quick Ratio | 1.08 |
| Debt / Equity | 0.30 |
| Debt / EBITDA | 4.56 |
| Debt / FCF | 3.60 |
| Interest Coverage | 3.37 |
Financial Efficiency
Return on equity (ROE) is 1.87% and return on invested capital (ROIC) is 0.63%.
| Return on Equity (ROE) | 1.87% |
| Return on Assets (ROA) | 0.49% |
| Return on Invested Capital (ROIC) | 0.63% |
| Return on Capital Employed (ROCE) | 1.13% |
| Revenue Per Employee | $313,223 |
| Profits Per Employee | $6,291 |
| Employee Count | 3,670 |
| Asset Turnover | 0.52 |
| Inventory Turnover | 6.48 |
Taxes
In the past 12 months, Omnicell has paid $13.06 million in taxes.
| Income Tax | 13.06M |
| Effective Tax Rate | 36.13% |
Stock Price Statistics
The stock price has decreased by -24.70% in the last 52 weeks. The beta is 0.78, so Omnicell's price volatility has been lower than the market average.
| Beta (5Y) | 0.78 |
| 52-Week Price Change | -24.70% |
| 50-Day Moving Average | 29.53 |
| 200-Day Moving Average | 36.49 |
| Relative Strength Index (RSI) | 62.52 |
| Average Volume (20 Days) | 572,801 |
Short Selling Information
The latest short interest is 2.04 million, so 4.45% of the outstanding shares have been sold short.
| Short Interest | 2.04M |
| Short Previous Month | 1.91M |
| Short % of Shares Out | 4.45% |
| Short % of Float | 4.56% |
| Short Ratio (days to cover) | 4.15 |
Income Statement
In the last 12 months, Omnicell had revenue of $1.15 billion and earned $23.09 million in profits. Earnings per share was $0.49.
| Revenue | 1.15B |
| Gross Profit | 504.45M |
| Operating Income | 17.45M |
| Pretax Income | -20.77M |
| Net Income | 23.09M |
| EBITDA | 74.08M |
| EBIT | 17.45M |
| Earnings Per Share (EPS) | $0.49 |
Balance Sheet
The company has $399.00 million in cash and $384.41 million in debt, giving a net cash position of $14.59 million or $0.32 per share.
| Cash & Cash Equivalents | 399.00M |
| Total Debt | 384.41M |
| Net Cash | 14.59M |
| Net Cash Per Share | $0.32 |
| Equity (Book Value) | 1.26B |
| Book Value Per Share | 27.22 |
| Working Capital | 250.38M |
Cash Flow
In the last 12 months, operating cash flow was $147.75 million and capital expenditures -$40.91 million, giving a free cash flow of $106.84 million.
| Operating Cash Flow | 147.75M |
| Capital Expenditures | -40.91M |
| Free Cash Flow | 106.84M |
| FCF Per Share | $2.33 |
Margins
Gross margin is 43.88%, with operating and profit margins of 1.52% and 2.01%.
| Gross Margin | 43.88% |
| Operating Margin | 1.52% |
| Pretax Margin | 3.14% |
| Profit Margin | 2.01% |
| EBITDA Margin | 6.44% |
| EBIT Margin | 1.52% |
| FCF Margin | 9.29% |
Dividends & Yields
Omnicell does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.30% |
| Shareholder Yield | -2.30% |
| Earnings Yield | 1.59% |
| FCF Yield | 7.38% |
Analyst Forecast
The average price target for Omnicell is $46.71, which is 48.19% higher than the current price. The consensus rating is "Buy".
| Price Target | $46.71 |
| Price Target Difference | 48.19% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | 15.20% |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Omnicell has an Altman Z-Score of 2.15 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.15 |
| Piotroski F-Score | 7 |